Inventor · disambiguated record
Iris Grossman
Also filed as: GROSSMAN IRIS
3 granted patents·11 pending applications·6 citations·filing 2006–2021
57Inventor score
Top patents by PatentIndex Score
14 records- 0180US9702007B2Genetic markers predictive of response to glatiramer acetateTCHELET AMIR·Filed 2014·Granted Jul 11, 2017·6 cites·20 claims
- 0256US10829561B2Antibodies targeting quiescin sulfhydryl oxidase (QSOX1) and uses of sameYEDA RES & DEV·Filed 2018·Granted Nov 10, 2020·0 cites·4 claims
- 0355US2021147575A1Antibodies targeting quiescin sulfhydryl oxidase (qsox1) and uses of sameYEDA RES & DEV·Filed 2021·Application pending·0 cites
- 0452US2021118524A1Identifying Therapeutic Targets by Discovering Interactions between Non-Coding Variants and Candidate GenesCAMP4 THERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 0550US9631028B2Compositions for inhibition of quiescin sulfhydryl oxidase (QSOX1) and uses of sameYEDA RES & DEV·Filed 2013·Granted Apr 25, 2017·0 cites·3 claims
- 0646US2018002753A1Genetic markers predictive of response to glatiramer acetateTCHELET AMIR·Filed 2017·Application pending·0 cites
- 0745US2010285600A1Markers associated with the therapeutic efficacy of glatiramer acetateTEVA PHARMA·Filed 2010·Application pending·0 cites
- 0844US2021292437A1Chimeric quiescin sulfhydryl oxidase (qsox1) antibodies and uses of sameYEDA RES & DEV·Filed 2019·Application pending·0 cites
- 0938US2017247468A1Compositions for inhibition of quiescin sulfhydryl oxidase (qsox1) and uses of sameYEDA RES & DEV·Filed 2017·Application pending·0 cites
- 1038US2006240463A1Markers associated with the therapeutic efficacy of glatiramer acetateTEVA PHARMA·Filed 2006·Application pending·0 cites
- 1137US2022107328A1Methods of treating liver diseasesCAMP4 THERAPEUTICS CORP·Filed 2019·Application pending·0 cites
- 1231US2015275302A1Determination of single nucleotide polymorphisms useful to predict response for rasagilineMASELLIS MARIO·Filed 2015·Application pending·0 cites
- 1329US2016312284A1Select single nucleotide polymorphisms predictive of response to glatiramer acetateGROSSMAN IRIS·Filed 2016·Application pending·0 cites
- 1426US2017003277A1Biological characterization of a glatiramer acetate related drug product using mammalian and human cellsHAYDEN MICHAEL·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →